4MatthewsS J. Entecavir for the treatment of chronic hepatitis B virus infection[J]. Clinical Therapeutics,2006,28:184-203.
5Ferir G, Kaptein S, Neyts J, et al.Antiviral treatment o~ehronic hepatitis B virus infections : the past, the present and the future[J].Rev Med Virol, 2008, 18(1) : 19-34.
6Liaw Y F, Chu C M.Hepatitis B virus infection[J].Lancet, 2009, 373(9663) : 582-592.
7Manesis E K, Hadziyannis S J.Interferon alpha treatment and retreatment of hepatitis B eantigen-negative chronic hepatitis[J].Gastroenterology, 2001, 121(1) : 101-109.
8Guidotti L G, Morris A, Mendea I-I, et al.[nterferon-regulated pathways that control hepatitis B birus replication in transgenic mice[J]. J Virol, 2002, 76(6) : 2617-2621.
9Wieland S F, Vega R G, Muller R, et al.Serching for interferon- induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes[J]. J Virol, 2003, 77(2) : 1227-1236.
10Fried M W, Piratrisuth T, Lau G K, et al.HBeAg and Hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HbeAg-positive chronic Hepatities B[J].Hepatology, 2008, 47(2) : 428- 434.
